Ajanta Pharma's Paithan facility received a USFDA Establishment Inspection Report (EIR), with the inspection classified as Voluntary Action Indicated (VAI). This outcome supports continued operations for the US market.

Ajanta Pharma LimitedAJANTPHARM · Filed with the exchange

No comments yet. Be the first.

More from Ajanta Pharma Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.